1/23/25 15:28 | 1/22/25 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S | -412 | 30.43 | 0 | -14 | -1 | 1,958 | D | | | | | | | | | | | | | | |
1/21/25 16:04 | 1/17/25 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S | -180 | 29.96 | 0 | -6 | 0 | 1,971 | D | | | | | | | | | | | | | | |
1/14/25 16:18 | 1/13/25 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S | -179 | 28.70 | 0 | -6 | 0 | 1,847 | D | | | | | | | | | | | | | | |
3/5/24 16:07 | 3/1/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | M.d | 1,050 | 4.20 | 0 | 250 | 14 | 2,035 | D | | | | | | | | | | | | | | |
3/5/24 16:07 | 3/1/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.d | -16,029 | 64.11 | 0 | -250 | -11 | 2,035 | D | | | | | | | | | | | | | | |
2/13/24 16:49 | 2/12/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S | -268 | 67.77 | 0 | -4 | 0 | 2,035 | D | | | | | | | | | | | | | | |
1/31/24 16:26 | 1/29/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S | -182 | 64.14 | 0 | -3 | 0 | 2,039 | D | | | | | | | | | | | | | | |
1/23/24 19:28 | 1/22/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S | -873 | 65.00 | 0 | -13 | -1 | 2,042 | D | | | | | | | | | | | | | | |
1/17/24 16:32 | 1/16/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.d | -525 | 66.81 | 0 | -8 | 0 | 2,055 | D | | | | | | | | | | | | | | |
11/21/23 17:36 | 11/21/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S | -244 | 48.80 | 0 | -5 | 0 | 1,991 | D | | | | | | | | | | | | | | |
9/1/23 16:05 | 9/1/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | M.d | 801 | 2.67 | 0 | 300 | 18 | 1,996 | D | | | | | | | | | | | | | | |
9/1/23 16:05 | 9/1/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.d | -6,263 | 41.75 | 0 | -150 | -7 | 1,996 | D | | | | | | | | | | | | | | |
5/18/23 17:10 | 5/16/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | M.dm | 134 | 2.67 | 0 | 50 | 3 | 1,846 | D | | | | | | | | | | | | | | |
5/18/23 17:10 | 5/16/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.d | -2,570 | 85.66 | 0 | -30 | -2 | 1,846 | D | | | | | | | | | | | | | | |
4/20/23 16:51 | 4/18/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | M.dm | 134 | 2.67 | 0 | 50 | 3 | 1,826 | D | | | | | | | | | | | | | | |
4/20/23 16:51 | 4/18/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.d | -2,461 | 82.02 | 0 | -30 | -2 | 1,826 | D | | | | | | | | | | | | | | |
3/23/23 16:55 | 3/21/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | M.dm | 610 | 3.88 | 0 | 157 | 10 | 1,806 | D | | | | | | | | | | | | | | |
3/23/23 16:55 | 3/21/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.d | -1,882 | 62.74 | 0 | -30 | -2 | 1,806 | D | | | | | | | | | | | | | | |
3/1/23 16:10 | 2/27/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | M.d | 376 | 3.76 | 0 | 100 | 6 | 1,679 | D | | | | | | | | | | | | | | |
12/21/22 16:13 | 12/19/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | M.d | 232 | 4.64 | 0 | 50 | 3 | 1,500 | D | | | | | | | | | | | | | | |
12/21/22 16:13 | 12/19/22 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.d | -1,468 | 52.06 | 0 | -28 | -2 | 1,500 | D | | | | | | | | | | | | | | |